“Ukatamanga weka utamangisa, tikatamanga awili, tifikapatali" - When you run alone, you run fast. When you run together, you run further - Zambian Proverb


Research and Training Programme


RESPIRE: The National Institute for Health Research's (NIHR) Global Respiratory Health Unit.

Sheikh A, Campbell H, Balharry D, Baqui AH, Bogaert D, Cresswell K, Cunningham S, Dockerell D, El Arifeen S, Fletcher M, Grant L, Ghazali SS, Habib M, Hazir T, Isaac R, Juvekar S, Khoo EM, McKinstry B, Morris AD, Nair H, Norrie J, Nwaru BI, Pinnock H, Robertson D, Saha S, Salvi S, Schwarze J, Simpson C, Sridhar D, Stoddart A, Weller D, Whyte M, Worth A, Williams S, Yusuf O, Zumla A, Rudan I; RESPIRE Collaboration.

J Glob Health. 2018 Dec;8(2):020101. doi: 10.7189/jogh.08.020101. No abstract available.

PMID: 30603074 

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants.

Zumla A, Abubakar I.

BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0.

PMID: 30497477 

Universal health coverage for refugees and migrants in the twenty-first century.

Abubakar I, Zumla A.

BMC Med. 2018 Nov 26;16(1):216. doi: 10.1186/s12916-018-1208-2.

PMID: 30474558 

Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era.

Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh TD, Ippolito G, Zumla A.

Int J Infect Dis. 2019 Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018 Nov 16. Review.

PMID: 30453097 

Achieving sustainable development goals for HIV/AIDS in the Republic of the Congo - Progress, obstacles and challenges in HIV/AIDS health services.

Ghoma Linguissi LS, Lucaccioni V, Bates M, Zumla A, Ntoumi F.

Int J Infect Dis. 2018 Dec;77:107-112. doi: 10.1016/j.ijid.2018.10.009. Epub 2018 Oct 17. Review.

PMID: 30342250

Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study.

Murphy ME, Wills GH, Murthy S, Louw C, Bateson ALC, Hunt RD, McHugh TD, Nunn AJ, Meredith SK, Mendel CM, Spigelman M, Crook AM, Gillespie SH; REMoxTB consortium.

BMC Med. 2018 Oct 17;16(1):189. doi: 10.1186/s12916-018-1169-5.

PMID: 30326959 

Advancing global tuberculosis control after the UNGA-HLM.

Marais B, Zumla A.

Lancet. 2018 Sep 29;392(10153):1096-1097. doi: 10.1016/S0140-6736(18)32361-4. Epub 2018 Sep 24. No abstract available.

PMID: 30262331

The historic and unprecedented United Nations General Assembly High Level Meeting on Tuberculosis (UNGA-HLM-TB)-'United to End TB: An Urgent Global Response to a Global Epidemic'.

Zumla A, Petersen E.

Int J Infect Dis. 2018 Oct;75:118-120. doi: 10.1016/j.ijid.2018.09.017. Epub 2018 Sep 19. No abstract available.

PMID: 30244078

Effectiveness of service models and organisational structures supporting tuberculosis identification and management in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review.

Heuvelings CC, Greve PF, de Vries SG, Visser BJ, Bélard S, Janssen S, Cremers AL, Spijker R, Shaw E, Hill RA, Zumla A, Sandgren A, van der Werf MJ, Grobusch MP.

BMJ Open. 2018 Sep 8;8(9):e019642. doi: 10.1136/bmjopen-2017-019642.

PMID: 30196265 

Children infected by human herpesvirus 6B with febrile seizures are more likely to develop febrile status epilepticus: A case-control study in a referral hospital in Zambia.

Tembo J, Chandwe K, Kabwe M, Chilufya M, Ciccone O, Mpabalwani E, Ablashi D, Zumla A, Chen T, Bates M.

J Med Virol. 2018 Nov;90(11):1757-1764. doi: 10.1002/jmv.25269. Epub 2018 Aug 13.

PMID: 30011348

Tuberculosis series.

Silva DR, Mello FCQ, Kritski A, Dalcolmo M, Zumla A, Migliori GB.

J Bras Pneumol. 2018 Apr;44(2):71-72. doi: 10.1590/s1806-37562018000020001. English, Portuguese. No abstract available.

PMID: 29791560

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.

Silva DR, Dalcolmo M, Tiberi S, Arbex MA, Munoz-Torrico M, Duarte R, D'Ambrosio L, Visca D, Rendon A, Gaga M, Zumla A, Migliori GB.

J Bras Pneumol. 2018 Apr;44(2):153-160. doi: 10.1590/s1806-37562017000000436. Review. Portuguese, English.

PMID: 29791557

Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis.

Murthy SE, Chatterjee F, Crook A, Dawson R, Mendel C, Murphy ME, Murray SR, Nunn AJ, Phillips PPJ, Singh KP, McHugh TD, Gillespie SH; REMoxTB Consortium.

BMC Med. 2018 May 21;16(1):73. doi: 10.1186/s12916-018-1053-3.

PMID: 29779492

Limiting consumption in tuberculosis: current concepts in anti-tuberculosis treatment in the critically ill patient.

Mer M, Zumla A, Dünser MW.

Intensive Care Med. 2018 Dec;44(12):2229-2231. doi: 10.1007/s00134-018-5161-5. Epub 2018 May 11. No abstract available.

PMID: 29752523

Mitigating the risks of global spread of Lassa fever at the 2018 Hajj pilgrimage.

Gautret P, Okolo S, Elachola H, Zumla A, Memish ZA.

Travel Med Infect Dis. 2018 May - Jun;23:99-100. doi: 10.1016/j.tmaid.2018.04.016. Epub 2018 Apr 27. No abstract available.

PMID: 29709659

Global spread of antibiotic-resistant bacteria and mass-gathering religious events.

Zumla A, Azhar EI, Hui DS, Shafi S, Petersen E, Memish ZA.

Lancet Infect Dis. 2018 May;18(5):488-490. doi: 10.1016/S1473-3099(18)30242-1. No abstract available.

PMID: 29695351

Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission.

Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A.

Lancet Infect Dis. 2018 Aug;18(8):e217-e227. doi: 10.1016/S1473-3099(18)30127-0. Epub 2018 Apr 18. Review.

PMID: 29680581

The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era.

Floyd K, Glaziou P, Zumla A, Raviglione M.

Lancet Respir Med. 2018 Apr;6(4):299-314. doi: 10.1016/S2213-2600(18)30057-2. Review.

PMID: 29595511

Tuberculosis research and development: seeding the future.

Lienhardt C, Zumla A, Gebreselassie N, Frick M, Gray G, Kasaeva T, Raviglione M.

Lancet Respir Med. 2018 Apr;6(4):242-244. doi: 10.1016/S2213-2600(18)30050-X. No abstract available.

PMID: 29595503

B cells or T cells in TB: a continuing conundrum.

Maeurer M, Rao M, Zumla A.

Lancet Respir Med. 2018 Apr;6(4):237-238. doi: 10.1016/S2213-2600(18)30080-8. No abstract available.

PMID: 29595500

Similar articles

Select item 2958081922.

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies.

Tiberi S, du Plessis N, Walzl G, Vjecha MJ, Rao M, Ntoumi F, Mfinanga S, Kapata N, Mwaba P, McHugh TD, Ippolito G, Migliori GB, Maeurer MJ, Zumla A.

Lancet Infect Dis. 2018 Jul;18(7):e183-e198. doi: 10.1016/S1473-3099(18)30110-5. Epub 2018 Mar 23. Review. Erratum in: Lancet Infect Dis. 2018 Apr 27;:.

PMID: 29580819

Similar articles

Select item 2958081823.

Tuberculosis: advances and challenges in development of new diagnostics and biomarkers.

Walzl G, McNerney R, du Plessis N, Bates M, McHugh TD, Chegou NN, Zumla A.

Lancet Infect Dis. 2018 Jul;18(7):e199-e210. doi: 10.1016/S1473-3099(18)30111-7. Epub 2018 Mar 23. Review.

PMID: 29580818

Similar articles

Select item 2958081724.

Concrete action now: UN High-Level Meeting on Tuberculosis.

Herbert N, Sharma V, Masham BS, Sheehan BS, Hauser J, Zumla A.

Lancet Infect Dis. 2018 Jul;18(7):709-710. doi: 10.1016/S1473-3099(18)30171-3. Epub 2018 Mar 23. No abstract available.

PMID: 29580817

Similar articles

Select item 2957157825.

Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB".

Tiberi S, Petersen E, Maeurer M, Ntoumi F, Yeboa-Manu D, Mwaba P, Vilaplana C, Dar O, Bates M, Corrah T, Rao M, Kapata N, Azhar EI, Memish ZA, Mfinanga S, Aseffa A, Ippolito G, Migliori GB, Zumla A.

Int J Infect Dis. 2018 Mar;68:122-124. doi: 10.1016/j.ijid.2018.03.002. Epub 2018 Mar 22. No abstract available.

Select item 2957111626.

The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection control.

Otu A, Hashmi M, Mukhtar AM, Kwizera A, Tiberi S, Macrae B, Zumla A, Dünser MW, Mer M.

J Crit Care. 2018 Jun;45:184-196. doi: 10.1016/j.jcrc.2018.03.015. Epub 2018 Mar 13. Review.

PMID: 29571116

Accelerating the development of therapeutic strategies for drug-resistant tuberculosis.

Vjecha MJ, Tiberi S, Zumla A.

Nat Rev Drug Discov. 2018 Sep;17(9):607-608. doi: 10.1038/nrd.2018.28. Epub 2018 Mar 23.

PMID: 29567994

Urgent need for multi-site controlled trials for CMV pneumonia treatment in African children.

Tembo J, Moraleda C, Rojo P, Zumla A, Bates M.

Int J Tuberc Lung Dis. 2018 Apr 1;22(4):469-470. doi: 10.5588/ijtld.17.0847. No abstract available.

PMID: 29563003

Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis.

Rao M, Valentini D, Zumla A, Maeurer M.

Int J Infect Dis. 2018 Apr;69:78-84. doi: 10.1016/j.ijid.2018.02.021. Epub 2018 Mar 2.

PMID: 29501835

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.

Roemer MGM, Redd RA, Cader FZ, Pak CJ, Abdelrahman S, Ouyang J, Sasse S, Younes A, Fanale M, Santoro A, Zinzani PL, Timmerman J, Collins GP, Ramchandren R, Cohen JB, De Boer JP, Kuruvilla J, Savage KJ, Trneny M, Ansell S, Kato K, Farsaci B, Sumbul A, Armand P, Neuberg DS, Pinkus GS, Ligon AH, Rodig SJ, Shipp MA.

J Clin Oncol. 2018 Apr 1;36(10):942-950. doi: 10.1200/JCO.2017.77.3994. Epub 2018 Feb 2.

PMID: 29394125 

Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C?

Ippolito G, Zumla A, Lanini S.

Clin Microbiol Infect. 2018 Apr;24(4):328-331. doi: 10.1016/j.cmi.2018.01.001. Epub 2018 Jan 8. Review. No abstract available.

PMID: 29326009

Reply to Reisler et al.

Lanini S, Portella G, Vairo F, Di Caro A, Kobinger G, Zumla A, Ippolito G.

Clin Infect Dis. 2018 Apr 17;66(9):1480-1481. doi: 10.1093/cid/cix1026. No abstract available.

PMID: 29272344

Advancing political will to end the tuberculosis epidemic.

Herbert N, Masham BS, Suttie BA, Sharma V, Albani S, Domenti O, Flurry R, Oliver M, Zumla A.

Lancet Infect Dis. 2018 Jul;18(7):711-712. doi: 10.1016/S1473-3099(17)30679-5. Epub 2017 Nov 15. No abstract available.

PMID: 29153268

Relationship Between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study.

Lanini S, Portella G, Vairo F, Kobinger GP, Pesenti A, Langer M, Kabia S, Brogiato G, Amone J, Castilletti C, Miccio R, Capobianchi MR, Strada G, Zumla A, Di Caro A, Ippolito G; INMI-EMERGENCY EBOV Sierra Leone Study Group .

Clin Infect Dis. 2018 Jan 6;66(1):36-44. doi: 10.1093/cid/cix704.